A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.

Completed

Conditions studied: Pancreatic Cancer

In brief

A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.

Key facts

Study ID

NCT02021500

Run by

Celgene

People needed

40

Starts

2014-01-02

Expected to finish

2015-04-16

Last updated by the study team

2019-11-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have been enrolled in the CA046 study Must have been living at the time of the last survival follow-up (approximate timeframe - end of March, 2013) Must understand and be able to give informed consent (if a subject is deceased, proper legal consent (ie, next of kin, legal representative) will be obtained prior to collection of data)

You may not qualify if…

• Consent refused for any reason

Where it is running

• TGen Clinical Research Services — Scottsdale, Arizona, United States
• Mayo Clinic — Scottsdale, Arizona, United States
• Pacific Shores Medical Group — Long Beach, California, United States
• University of Colorado Cancer Center — Aurora, Colorado, United States
• Florida Cancer Specialists — Englewood, Florida, United States
• Florida Cancer Specialist — Tavares, Florida, United States
• Indiana University — Indianapolis, Indiana, United States
• University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
• Arena Oncology Associates — Lake Success, New York, United States
• UPMC Cancer Pavillion — Pittsburgh, Pennsylvania, United States
• Tennessee Oncology PLLC — Nashville, Tennessee, United States
• South Texas Oncology and Hematology (STOH) — San Antonio, Texas, United States
• Fairfax-Northern Virginia Haematology-Oncology — Fairfax, Virginia, United States
• Virginia Cancer Institute — Richmond, Virginia, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
• Froedtert and Medical College ID Clinic — Milwaukee, Wisconsin, United States
• Macarthur Cancer Therapy Centre — Campbelltown, New South Wales, Australia
• Prince of Wales Hospital — Randwick, New South Wales, Australia
• HOCA - the Wesley Clinic for Heamatology and Oncology — Auchenflower, Queensland, Australia
• Mater Medical Center — South Brisbane, Australia
• Landesklinikum St. Pölten — Sankt Pölten, Austria
• Medizinische Universität Wien — Vienna, Austria
• Klinikum Wels-Grieskirchen GmbH — Wels, Austria
• Tom Baker Cancer Centre — Calgary, Alberta, Canada
• British Columbia Cancer Agency — Vancouver, British Columbia, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.